Analyst firms · Robert W. Baird · ARGX
Robert W. Baird ARGX price target and rating history
argenx SE (ARGX) · Health Care
Robert W. Baird rates argenx SE (ARGX) Neutral with a $858 price target, as of its latest action on Dec 18, 2025. It has published 5 rating actions on ARGX since July 2022, including 2 upgrades and 3 downgrades. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185. Robert W. Baird's $858 is 28% below that.
- Current rating
- Neutral
- Price target
- $858
- Median target, all firms
- $1,185
- Actions on ARGX
- 5
Robert W. Baird price target on ARGX
Every Robert W. Baird rating on ARGX
- Dec 18, 2025
- May 13, 2025
- Nov 1, 2024
- Mar 14, 2023
- Jul 29, 2022
How other firms rate ARGX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $1,400 | Aug 26, 2026 |
| Deutsche Bank | Hold | Aug 24, 2026 | |
| Guggenheim | Buy | $1,185 | Aug 4, 2026 |
| Robert W. Baird | Neutral | $858 | Dec 18, 2025 |
| Wolfe Research | Peer Perform | Nov 24, 2025 |
Questions about Robert W. Baird and ARGX
- What is Robert W. Baird's price target for ARGX?
- Robert W. Baird's latest stated price target for argenx SE (ARGX) is $858, from its action on Dec 18, 2025.
- What is Robert W. Baird's rating on ARGX?
- Robert W. Baird rates ARGX Neutral, a neutral rating, as of Dec 18, 2025.
- When did Robert W. Baird last change its view on ARGX?
- On Dec 18, 2025, Robert W. Baird downgrades to Neutral from Outperform, price target $858.
- How does Robert W. Baird's ARGX target compare with other analysts?
- Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185. Robert W. Baird's $858 is 28% below that.
More ARGX rating histories
All Robert W. Baird ratingsARGX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.